Peptide compound
GIP / GLP Dual Agonist
Dual GIP and GLP-1 receptor agonist (tirzepatide-class).
$90Starting · per vial
— Tracked fulfillment · COA included · Discreet packaging
Purity
>99%
Form
Lyophilized
Storage
-20°C
Grade
Research
— Overview
GIP / GLP Dual Agonist at a glance.
A dual-action incretin agonist targeting both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Research focuses on combined incretin signaling, glucose homeostasis, and body-composition outcomes in metabolic-disease models.
— Often paired with
Related compounds.
— Want supervision?
Pair GIP / GLP Dual Agonist with a
physician-designed protocol.
Stria Performance and Complete tiers include physician-prescribed peptides with comprehensive labs and quarterly follow-up. Take the assessment to see which fits.